Hidefumi Wada

1.1k total citations
19 papers, 342 citations indexed

About

Hidefumi Wada is a scholar working on Oncology, Dermatology and Epidemiology. According to data from OpenAlex, Hidefumi Wada has authored 19 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Dermatology and 7 papers in Epidemiology. Recurrent topics in Hidefumi Wada's work include Cancer and Skin Lesions (7 papers), Nonmelanoma Skin Cancer Studies (5 papers) and Hedgehog Signaling Pathway Studies (3 papers). Hidefumi Wada is often cited by papers focused on Cancer and Skin Lesions (7 papers), Nonmelanoma Skin Cancer Studies (5 papers) and Hedgehog Signaling Pathway Studies (3 papers). Hidefumi Wada collaborates with scholars based in Japan, Russia and United States. Hidefumi Wada's co-authors include Tomio Inoue, Izumi Koike, Masaharu Hata, Etsuko Miyagi, Takashi Shimamoto, Kazumasa Odagiri, Kazuo Noguchi, Yuki Mukai, Masahiro Yao and Ichiro Ogino and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Hidefumi Wada

17 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hidefumi Wada Japan 11 194 187 132 123 40 19 342
Tina Petrogiannis‐Haliotis Canada 9 71 0.4× 164 0.9× 61 0.5× 37 0.3× 61 1.5× 17 323
Sudip Thakar United States 9 59 0.3× 182 1.0× 117 0.9× 74 0.6× 70 1.8× 14 304
Dušan Daniš Czechia 8 185 1.0× 135 0.7× 65 0.5× 130 1.1× 8 0.2× 11 334
Shachar Sade Canada 10 93 0.5× 89 0.5× 67 0.5× 33 0.3× 32 0.8× 21 218
Yun-Yi Kong China 11 97 0.5× 103 0.6× 72 0.5× 67 0.5× 26 0.7× 16 302
Nicholas D. L. Brougham New Zealand 5 254 1.3× 205 1.1× 298 2.3× 42 0.3× 14 0.3× 7 398
Laura Del Regno Italy 9 101 0.5× 140 0.7× 114 0.9× 53 0.4× 26 0.7× 24 263
Farah Succaria United States 8 58 0.3× 106 0.6× 37 0.3× 34 0.3× 59 1.5× 17 233
David Eilers United States 9 204 1.1× 114 0.6× 196 1.5× 41 0.3× 21 0.5× 19 297
Beatriz Fernández‐Jorge Spain 11 122 0.6× 59 0.3× 88 0.7× 20 0.2× 9 0.2× 29 280

Countries citing papers authored by Hidefumi Wada

Since Specialization
Citations

This map shows the geographic impact of Hidefumi Wada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidefumi Wada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidefumi Wada more than expected).

Fields of papers citing papers by Hidefumi Wada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidefumi Wada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidefumi Wada. The network helps show where Hidefumi Wada may publish in the future.

Co-authorship network of co-authors of Hidefumi Wada

This figure shows the co-authorship network connecting the top 25 collaborators of Hidefumi Wada. A scholar is included among the top collaborators of Hidefumi Wada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidefumi Wada. Hidefumi Wada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Nakamura, Motoki, Kotaro Nagase, Hiroshi Kato, et al.. (2020). Glucose-6-phosphate dehydrogenase correlates with tumor immune activity and programmed death ligand-1 expression in Merkel cell carcinoma. Journal for ImmunoTherapy of Cancer. 8(2). e001679–e001679. 18 indexed citations
2.
Tokita, Takashi, Takashi Kawahara, Yusuke Ito, et al.. (2018). Primary amelanotic malignant melanoma of the male urethra with inguinal lymph node metastasis successfully controlled by nivolumab: A case report. Urology Case Reports. 18. 54–56. 10 indexed citations
3.
Yamazaki, Naoya, Tatsuya Takenouchi, Manabu Fujimoto, et al.. (2017). Phase 1b study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced melanoma (KEYNOTE-041). Cancer Chemotherapy and Pharmacology. 79(4). 651–660. 73 indexed citations
4.
Yamazaki, Naoya, Hisashi Uhara, Hidefumi Wada, et al.. (2016). Phase I study of pegylated interferon‐alpha‐2b as an adjuvant therapy in Japanese patients with malignant melanoma. The Journal of Dermatology. 43(10). 1146–1153. 8 indexed citations
5.
Yokota, Kenji, Tatsuya Takenouchi, Masahiro Fujimoto, et al.. (2015). 3325 Safety and efficacy of Pembrolizumab (MK-3475) for Japanese patients (pts) with advanced melanoma: Preliminary results from KEYNOTE-041 Phase 1b study. European Journal of Cancer. 51. S672–S672. 1 indexed citations
6.
Hata, Masaharu, Hidefumi Wada, Ichiro Ogino, et al.. (2014). Radiation therapy for angiosarcoma of the scalp. Strahlentherapie und Onkologie. 190(10). 899–904. 21 indexed citations
7.
Hata, Masaharu, Izumi Koike, Hidefumi Wada, et al.. (2014). Postoperative radiation therapy for extramammary Paget's disease. British Journal of Dermatology. 172(4). 1014–1020. 28 indexed citations
8.
Hata, Masaharu, et al.. (2013). Radiation therapy for lymph node metastasis from extramammary Paget's disease. Journal of the European Academy of Dermatology and Venereology. 28(7). 873–877. 17 indexed citations
9.
Hata, Masaharu, Izumi Koike, Hidefumi Wada, et al.. (2013). Radiation therapy for extramammary Paget's disease: treatment outcomes and prognostic factors. Annals of Oncology. 25(1). 291–297. 31 indexed citations
10.
Hata, Masaharu, Izumi Koike, Hidefumi Wada, et al.. (2012). Definitive radiation therapy for extramammary Paget's disease.. PubMed. 32(8). 3315–20. 10 indexed citations
11.
Wada, Hidefumi, Ryoji Tsuboi, Yukihiko Kato, et al.. (2012). Phase I and pharmacokinetic study of the oral histone deacetylase inhibitor vorinostat in Japanese patients with relapsed or refractory cutaneous T‐cell lymphoma. The Journal of Dermatology. 39(10). 823–828. 18 indexed citations
12.
Koike, Tomoyuki, et al.. (2012). Recurrent endocrine mucin‐producing sweat gland carcinoma in the eyelid. Australasian Journal of Dermatology. 54(2). e46–9. 15 indexed citations
13.
Hata, Masaharu, Motoko Omura, Izumi Koike, et al.. (2010). Role of Radiotherapy as Curative Treatment of Extramammary Paget’s Disease. International Journal of Radiation Oncology*Biology*Physics. 80(1). 47–54. 36 indexed citations
14.
Miyamoto, Hideaki & Hidefumi Wada. (2009). Localized multiple glomangiomas on the foot. The Journal of Dermatology. 36(11). 604–607. 4 indexed citations
15.
Nagatani, Tetsuo, et al.. (2007). Treatment of mycosis fungoides with PUVA: Long-term follow-up. Skin Cancer. 22(2). 183–189. 1 indexed citations
16.
Ogawa, Toru, Yoji Nagashima, Hidefumi Wada, et al.. (2005). Extramammary Paget's disease: analysis of growth signal pathway from the human epidermal growth factor receptor 2 protein. Human Pathology. 36(12). 1273–1280. 49 indexed citations
17.
Tamura, Nobuko, et al.. (1999). Two Cases of Aquired Segmental Anhidrosis.. The Nishinihon Journal of Dermatology. 61(1). 27–31.
18.
Ueno, Hideki, et al.. (1983). Light and electron microscopic studies of malignant melanoma of conjunctiva and palpebra.. PubMed. 27(3). 459–67. 2 indexed citations
19.
Kobayashi, Osamu, et al.. (1971). Extrarenal symptomatic glomerulonephritis in children.. PubMed. 19(1). 66–74.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026